McKesson Q2 adjusted EPS $9.86, +39% YoY; revenue record $103.2B; raises FY26 guidance

MCKESSON CORP

2026-Q2 EPS reported $15.16 revenue$200,977,000,000

Quarterly revenue $103.2B (+10% YoY); GAAP EPS $8.92 vs $1.87; adjusted EPS $9.86 vs $7.07 (+39%).
Generated $2.2B free cash flow in Q2; cash from operations $2.4B.
Raised FY26 adjusted EPS guidance to $38.35-$38.85 (prev. $38.05-$38.55), indicating 16-18% growth.
CEO Brian Tyler cites strength in oncology/multispecialty and biopharma services as growth drivers.
Record first-half revenue of $201B (+16% YoY); net income $1.89B, up 64%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.